Key facts
- This page summarizes Dr. Raluca Dinu's Form 4 filing for QT IMAGING HOLDINGS, INC. (QTIH).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 23 Apr 2025, 17:37.
Dr. Raluca Dinu - 21 Apr 2025 Form 4 Insider Report for QT IMAGING HOLDINGS, INC. (QTIH)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- QTIH
- Reported as of
- 21 Apr 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Apr 2025, 17:37:23 UTC
- Prior SEC filing
- 10 Apr 2025
- Next SEC filing
- 13 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dr. Raluca Dinu
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Dr. Raluca Dinu filed Form 4 for QT IMAGING HOLDINGS, INC. (QTIH) on 23 Apr 2025.
Change
- Previous filing in this sequence was filed on 10 Apr 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QTIH
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +75,000
- Change %
- Price
- $0.000000
- Shares after
- 75,000
- Date
- 21 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $0.6650
- Footnotes
- F1
QTIH
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +233,750
- Change %
- Price
- $0.000000
- Shares after
- 233,750
- Date
- 21 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 233,750
- Exercise price
- $0.6650
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
One-third of the grant will vest on February 15, 2026, and the remaining two thirds will vest in eight equal quarterly installments on each subsequent May 15, August 15, November 15 and February 15, such that the grant will be fully vested on February 15, 2028, subject to continued service with the Issuer through each vesting date.
Footnote F2
The grant will vest in four equal quarterly installments beginning on May 15, 2025, and continuing on August 15, 2025, November 15, 2025 and February 15, 2026, such that the grant will be fully vested on February 15, 2026, subject to continued service with the Issuer through each vesting date.